Navigation Links
Aspirin May Reduce Risk of Liver Cancer, Death From Liver Disease
Date:11/28/2012

WEDNESDAY, Nov. 28 (HealthDay News) -- Aspirin use seems to be associated with a decreased risk of liver cancer and death from chronic liver disease, according to a large new study.

This new study included more than 300,000 people aged 50 to 71, who reported their aspirin and nonsteroidal anti-inflammatory drug (NSAID) use and were followed for 10 to 12 years. During that time, more than 400 participants died from chronic liver disease and 250 were diagnosed with liver cancer.

Compared to people who didn't take NSAIDs, people who took aspirin were 45 percent less likely to die from chronic liver disease and 41 percent less likely to be diagnosed with liver cancer. People who took non-aspirin NSAIDs were 26 percent less likely to die from chronic liver disease but no less likely to be diagnosed with liver cancer.

If these findings are confirmed, they could lead to new ways to prevent chronic liver disease and liver cancer, concluded study author Dr. Vikrant Sahasrabuddhe, of the division of cancer epidemiology and genetics at the U.S. National Cancer Institute, and colleagues.

While the study found an association between aspirin use and reduced risk for liver problems, it did not prove cause-and-effect.

The study was published Nov. 28 in the Journal of the National Cancer Institute.

Previous research has linked chronic inflammation due to liver disease to cellular processes that could promote cancer development, while other research has suggested that aspirin and other types of NSAIDs may help reduce the risk of some cancers, a journal news release noted.

Although it is worthwhile to study the potential of new prevention methods such as NSAID use, it also is necessary to focus on improving established prevention practices and interventions, Dr. Isra Levy and Dr. Carolyn Pim, both from the department of epidemiology and community medicine at the University of Ottawa, in Canada, noted in an accompanying journal editorial.

The known causes of chronic liver disease and liver cancer are hepatitis B and C virus infections and alcohol use. A link with obesity and diabetes also has been suggested.

Cheap, readily available interventions, such as vaccines for hepatitis B and C virus, already exist, but "effective strategies for reduction of [hepatitis B] and [hepatitis C] are not always available or fully applied," the editorialists wrote.

They also noted that alcohol abuse and obesity are complex issues that require interventions at the individual and health-system levels.

More information

The American Liver Foundation outlines 25 ways to love your liver.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute, news release, Nov. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Daily Aspirin May Help Those at Risk for Recurrent Blood Clots
2. Daily Aspirin May Bolster Aging Brain, Study Shows
3. Genes May Determine Aspirins Effect on Advanced Colon Cancer
4. Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy
5. Adding Plavix to Aspirin Doesnt Help Guard Against Second Stroke: Study
6. Aspirin may help men with prostate cancer live longer, study suggests
7. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
8. Daily Aspirin May Cut Cancer Deaths, Another Study Finds
9. Daily aspirin usage associated with lower cancer mortality
10. Study adds to evidence daily aspirin linked to lower cancer mortality
11. Aspirin protects against Barretts esophagus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin May Reduce Risk of Liver Cancer, Death From Liver Disease
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company dedicated ... met with big-name retail buyers at the January ECRM Trade Show in Hilton Head, ... the utmost safety standards in all of its creations to help create a more ...
(Date:1/21/2017)... ... ... Salveo for life, a company that distributes an effervescent lime-flavored drink called ... part of its presence to expand its market reach. , Using a formula developed ... nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, whilst supporting ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming Home ... and community. “Coming Home 2017” will be held on Friday January 27 ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... ... 20, 2017 , ... Source Vitál Apothecary, a skin and body care company ... the company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports ... work in the nutritional, sports and health industries a chance to meet in private ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 Many patients don,t realize that they ... a pharmacy just a few blocks away charges only ... problem Medicationdiscountcard.com has created a price comparison ... much their medication will cost at most nearby pharmacies. ... Medicationdiscountcard.com takes all of the ...
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
Breaking Medicine Technology: